🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study will investigate changes in the structure and function of blood v...
Status
Unknown
Location
Toronto Western Hospital
Start Date
2009-07
Trial ID
NCT01196325
Retinal vein occlusion (RVO) may lead to series of complications including ...
Status
Unknown
Location
Chuangxin Huang
Start Date
2019-10-01
Trial ID
NCT04062370
Treatments Being Tested
This study evaluates long-term safety in patients with macular edema due to...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2010-08
Trial ID
NCT01198327
Treatments Being Tested
The purpose of the study is to find out if treatment with an intravitreal i...
Status
Completed
Location
Sall Research Medical Center
Start Date
2007-03
Trial ID
NCT00445003
Treatments Being Tested
To evaluate, specifically within the Canadian medical environment, the effi...
Status
Completed
Location
Calgary Retina Consultants
Start Date
2010-07
Trial ID
NCT01135914
Treatments Being Tested
Study of efficacy and safety of 0.5 mg ranibizumab in Chinese patients with...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-11-05
Trial ID
NCT02259088
Treatments Being Tested
Background: Age-related macular degeneration (AMD) is a common eye disease ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-01
Trial ID
NCT07744204
Treatments Being Tested
The objective of this clinical trial is to compare and evaluate the safety ...
Status
Unknown
Location
Hallym University Kangnam Sacred Heart Hospital
Start Date
2018-01-08
Trial ID
NCT03759860
The primary objective of the protocol is to determine if intravitreal ranib...
Status
Unknown
Location
Elman Retina Group
Start Date
2018-06-01
Trial ID
NCT03609996
Treatments Being Tested
This study was designed to confirm the efficacy and safety of ranibizumab (...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-09
Trial ID
NCT00989989
Treatments Being Tested